Elevation of serum
sialic acid and the
ST6Gal-1 sialyltransferase is part of the hepatic system inflammatory response, but the contribution of
ST6Gal-1 has remained unclear. Hepatic
ST6Gal-1 elevation is mediated by P1, 1 of 6 promoters regulating the ST6Gal1 gene. We report that the P1-ablated mouse, Siat1DeltaP1, and a globally ST6Gal-1-deficient mouse had significantly increased peritoneal
leukocytosis after intraperitoneal challenge with thioglycollate. Exaggerated
peritonitis was accompanied by only a modest increase in neutrophil viability, and transferred bone marrow-derived neutrophils from Siat1DeltaP1 mice migrated to the peritonea of recipients with normal efficiency after thioglycollate challenge. Siat1DeltaP1 mice exhibited 3-fold greater neutrophilia by thioglycollate, greater pools of
epinephrine-releasable marginated neutrophils, greater sensitivity to
G-CSF, elevated bone marrow CFU-G and proliferative-stage myeloid cells, and a more robust recovery from
cyclophosphamide-induced myelosuppression. Bone marrow leukocytes from Siat1DeltaP1 are indistinguishable from those of wild-type mice in alpha2,6-sialylation, as revealed by the Sambucus nigra
lectin, and in the expression of total
ST6Gal-1 mRNA. Together, our study demonstrated a role for
ST6Gal-1, possibly from extramedullary sources (eg, produced in liver) in regulating
inflammation, circulating neutrophil homeostasis, and replenishing granulocyte numbers.